Next report date
Report period
Q1 2024
EPS estimate
0.26EUR
Revenue estimate
219.69 MEUR
1.120EUR
86.19 MEUR
874.28 MEUR
34.12 M
About HISAMITSU PHARMACEUTICAL CO. INC.
Sector
Headquarters
Tosu
Founded
1847
Website
ISIN
JP3784600003
FIGI
BBG000C5XNC4
Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. Its products are sold under Salonpas, Salonsip, Mohrus, ByeBye-Fever, and Keplat brands. It also provides ethical pharmaceuticals, over- the-counter drugs, medical devices, health supplements, and topical analgesic products. The company was founded by Nihei Hisamitsu in 1847 and is headquartered in Tosu, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange HISAMITSU PHARMACEUTICAL CO. INC. stocks are traded under the ticker HPX.
HISAMITSU PHARMACEUTICAL CO. INC. is going to release the next earnings report on Jul 4, 2024. Keep track of upcoming events with our Earnings Calendar.
HPX earnings for the last quarter are 0.15 EUR per share, whereas the estimation was 0.16 EUR resulting in a −7.84% surprise. The estimated earnings for the next quarter are 0.13 EUR per share. See more details about HISAMITSU PHARMACEUTICAL CO. INC. earnings.
HISAMITSU PHARMACEUTICAL CO. INC. revenue for the last quarter amounts to 215.56 M EUR despite the estimated figure of 208.19 M EUR. In the next quarter revenue is expected to reach 424.27 M EUR.
Yes, you can track HISAMITSU PHARMACEUTICAL CO. INC. financials in yearly and quarterly reports right on TradingView.
HPX net income for the last quarter is 11.48 M EUR, while the quarter before that showed 22.88 M EUR of net income which accounts for −49.84% change. Track more HISAMITSU PHARMACEUTICAL CO. INC. financial stats to get the full picture.
HISAMITSU PHARMACEUTICAL CO. INC. dividend yield was 2.19% in 2023, and payout ratio reached 46.80%. The year before the numbers were 2.21% and 57.10% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, HPX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HISAMITSU PHARMACEUTICAL CO. INC. stock right from TradingView charts — choose your broker and connect to your account.
We've gathered analysts' opinions on HISAMITSU PHARMACEUTICAL CO. INC. future price: according to them, HPX price has a max estimate of 23.99 EUR and a min estimate of 23.99 EUR. Read a more detailed HISAMITSU PHARMACEUTICAL CO. INC. forecast: see what analysts think of HISAMITSU PHARMACEUTICAL CO. INC. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HISAMITSU PHARMACEUTICAL CO. INC. EBITDA is 112.67 M EUR, and current EBITDA margin is 12.94%. See more stats in HISAMITSU PHARMACEUTICAL CO. INC. financial statements.